Literature DB >> 33469810

Rescue Therapy with Intensive Vedolizumab Optimization in a Seventeen-Year-Old Girl with Acute Severe Ulcerative Colitis.

Francesco Graziano1, Fabio Salvatore Macaluso2, Nicola Cassata3, Michele Citrano3, Ambrogio Orlando2.   

Abstract

Entities:  

Year:  2021        PMID： 33469810     DOI： 10.1007/s10620-021-06826-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  3 in total

1.  Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis.

Authors:  Shaji Sebastian; Sally Myers; Konstantinos Argyriou; Gayle Martin; Louis Los; Joseph Fiske; Ravi Ranjan; Benjamin Cooper; Vivek Goodoory; Hey-Long Ching; NishaniLalanthika Jayasooriya; Johanne Brooks; Anjan Dhar; Achut H Shenoy; Jimmy K Limdi; Jeffrey Butterworth; Patrick B Allen; Sunil Samuel; Gordon W Moran; Richard Shenderey; Gareth Parkes; Alan Lobo; Nicholas A Kennedy; Sreedar Subramanian; Tim Raine
Journal:  Aliment Pharmacol Ther       Date:  2019-09       Impact factor: 8.171

2.  Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis.

Authors:  Matthew C Choy; Dean Seah; David M Faleck; Shailja C Shah; Che-Yung Chao; Yoon-Kyo An; Graham Radford-Smith; Talat Bessissow; Marla C Dubinsky; Alexander C Ford; Leonid Churilov; Neville D Yeomans; Peter P De Cruz
Journal:  Inflamm Bowel Dis       Date:  2019-06-18       Impact factor: 5.325

Review 3.  Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn's Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis.

Authors:  Laurent Peyrin-Biroulet; Silvio Danese; Marjorie Argollo; Lieven Pouillon; Spyros Peppas; Marien Gonzalez-Lorenzo; Theodore Lytras; Stefanos Bonovas
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-20       Impact factor: 11.382
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.